Compound Oyster Peptide Capsule
Product Images NDC 85631-004

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Compound Oyster Peptide (NDC 85631-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bispit Canada Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labeling (85631 004 01)

Pack label for Bispit Compound Oyster Peptide Tablet dietary supplement. The front highlights its purpose to improve physical energy and sexual quality, specifying 60 tablets at 1.2g each. The text panel lists active ingredients including Asian ginseng and oyster, with inactive ingredient calcium carbonate. Manufacturer is Bispit Canada Ltd, located in Vancouver, BC, Canada. The label includes a barcode and certifications like FDA registered facility and GMP compliance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.